Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results ...

Maziar Mike Doustdar takes over at Novo Nordisk as the company reports weaker earnings than expected on generic challenges to ...

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today ...

Novo Nordisk (NVO) is on pace to gap lower at the opening bell today, with shares of the pharma giant plunging up to 30% in ...

Emerging technology is becoming increasingly crucial to the efficiency and success of health systems. Forty-nine healthcare leaders spoke with Becker’s about the emerging technology that has surprised ...

Table of Contents The Simple Timing Trick That Changed Everything for Me The Nutrients That Don’t Play Nice Together What […] ...

An accompanying episode of the Annals of Family Medicine Podcast, featuring study authors Ann Sinéad Doherty, PhD, and Emma ...

The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?

A new clinical trial shows that combining dapagliflozin with insulin improves kidney health and blood sugar control, and ...

Amgen AMGN and Novo Nordisk NVO are among the largest companies in the pharmaceutical space. Amgen boasts one of the largest ...

As Europe’s healthcare systems grapple with aging populations, rising chronic disease, and overburdened clinicians, digital ...

The Global Regenerative Medicine Market, valued at approximately USD 34.56 billion in 2023, is projected to witness an exponential surge, growing at a compound annual growth rate ...